AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32968194 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational physical activity
Number of subjects: 252
Study 32968194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports physical activity
Number of subjects: 252
Study 32968194 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure time/commuting physical activity
Number of subjects: 252
Study 32968194 — intervention group
Group type: EXPERIMENTAL
Intervention: Total physical activity
Number of subjects: 252
Study 35617452 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% glycolic acid (GA) applied once every fortnight for a total of three times
Number of subjects: 30
Study 35617452 — intervention group
Group type: COMPARATOR
Intervention: Adapalene gel applied every night (control)
Number of subjects: 30
Study 35617452 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% glycolic acid (GA)
Number of subjects: 30
Study 34471992 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 4 weeks (Q4W)
Number of subjects: 0
Study 34471992 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab 300 mg (weekly until Week 4, then Q4W)
Number of subjects: 0
Study 35853465 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery counseling with spiritual content
Number of subjects: 60
Study 35853465 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35815097 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lifestyle counselling sessions during pregnancy and postpartum
Number of subjects: 2099
Study 35815097 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care (Control Group)
Number of subjects: 2099
Study 35815097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation (DHA, iron, vitamin D)
Number of subjects: 2099
Study 35815097 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational level, advanced age, primiparity, vegetarian diet
Number of subjects: 2099
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin locking
Number of subjects: 48
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (SQH) 7,500 units TID
Number of subjects: 48
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (SQH) 5,000 units
Number of subjects: 48
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (SQH) 7,500 units vs 5,000 units
Number of subjects: 48
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic anticoagulation
Number of subjects: 48
Study 33290813 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher D-dimer levels
Number of subjects: 48
Study 35994096 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory control training (3 sessions)
Number of subjects: 61
Study 35994096 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (no training)
Number of subjects: 61
Study 32495306 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored education intervention to promote physical activity and reduce salt intake, conducted through two educational sessions with follow-up at 3 months.
Number of subjects: 0
Study 32495306 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 32495306 — intervention group
Group type: COMPARATOR
Intervention: Both intervention and control groups.
Number of subjects: 0
Study 32536366 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted metal chain blanket
Number of subjects: 120
Study 32536366 — intervention group
Group type: COMPARATOR
Intervention: Light plastic chain blanket
Number of subjects: 120
Study 33566149 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 360
Study 33566149 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 360
Study 33566149 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 360
Study 33566149 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-involving DME at baseline in the fellow eye
Number of subjects: 360
Study 33566149 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subject age
Number of subjects: 360
Study 33566149 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline study eye ETDRS score
Number of subjects: 360
Study 32458286 — intervention group
Group type: EXPERIMENTAL
Intervention: Right lateral decubitus starting position
Number of subjects: 185
Study 32458286 — intervention group
Group type: COMPARATOR
Intervention: Left lateral decubitus starting position
Number of subjects: 185
Study 34195866 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot + normobaric hypoxic (HH)
Number of subjects: 11
Study 34195866 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 11
Study 34195866 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP)
Number of subjects: 11
Study 35160235 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 30 min sessions, 2 sessions per day for 5 days)
Number of subjects: 39
Study 35160235 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 39
Study 34842135 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant continuation (maintenance group)
Number of subjects: 478
Study 34842135 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant discontinuation (discontinuation group)
Number of subjects: 478
Study 34918163 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with stress
Number of subjects: 39
Study 32776493 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume low-intensity resistance exercise (HV-LRE)
Number of subjects: 22
Study 32776493 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise (HRE)
Number of subjects: 22
Study 34244118 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS)
Number of subjects: 348
Study 34244118 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Laparoscopic Prostatectomy (RALP)
Number of subjects: 348
Study 33215550 — intervention group
Group type: EXPERIMENTAL
Intervention: STVQT before ventricular arrhythmia
Number of subjects: 2331
Study 33215550 — intervention group
Group type: EXPERIMENTAL
Intervention: STVQT in nonsustained ventricular arrhythmia
Number of subjects: 2331
Study 33215550 — intervention group
Group type: EXPERIMENTAL
Intervention: STVQT in nonsustained ventricular tachycardia
Number of subjects: 2331
Study 33215550 — intervention group
Group type: EXPERIMENTAL
Intervention: STVQT in sustained ventricular tachycardia
Number of subjects: 2331
Study 33215550 — intervention group
Group type: COMPARATOR
Intervention: STVQT in control group
Number of subjects: 2331
Study 33215550 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of STVQT increase in sustained vs nonsustained ventricular arrhythmia
Number of subjects: 2331
Study 34666507 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line aspiration
Number of subjects: 205
Study 34666507 — intervention group
Group type: COMPARATOR
Intervention: Stent retriever thrombectomy
Number of subjects: 205
Study 33902334 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi/Qigong (TCQ)
Number of subjects: 13
Study 33902334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 13
Study 33902334 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred program
Number of subjects: 13
Study 34008144 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept
Number of subjects: 0
Study 34008144 — intervention group
Group type: COMPARATOR
Intervention: Colchicine and nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0
Study 34654487 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mentoring intervention
Number of subjects: 276
Study 33107460 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo R
Number of subjects: 60
Study 33107460 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐RaCe
Number of subjects: 60
Study 33107460 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper R
Number of subjects: 60
Study 33107460 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐Endo
Number of subjects: 60
Study 34185584 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone treatment
Number of subjects: 104
Study 34185584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 32293822 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing
Number of subjects: 0
Study 32293822 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic screening
Number of subjects: 0
Study 33992567 — intervention group
Group type: EXPERIMENTAL
Intervention: Carillon device
Number of subjects: 95
Study 33992567 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 95
Study 35727392 — intervention group
Group type: COMPARATOR
Intervention: RIPC alone
Number of subjects: 185
Study 35727392 — intervention group
Group type: COMPARATOR
Intervention: Nitrates alone
Number of subjects: 185
Study 35727392 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC + Nitrates
Number of subjects: 185
Study 35727392 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrates + RIPC
Number of subjects: 185
Study 32892655 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg tablet (formulation 1)
Number of subjects: 31
Study 32892655 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg tablet (formulation 2)
Number of subjects: 31
Study 33818398 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 (husband invitation, standard counseling)
Number of subjects: 782
Study 33818398 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 (no husband invitation, targeted counseling)
Number of subjects: 782
Study 33818398 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 (husband invitation, targeted counseling)
Number of subjects: 782
Study 33818398 — intervention group
Group type: COMPARATOR
Intervention: T0 (no husband invitation, standard counseling)
Number of subjects: 782
Study 32246251 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (FTY)
Number of subjects: 629
Study 32246251 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF)
Number of subjects: 629
Study 32246251 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide (TERI)
Number of subjects: 629
Study 32008386 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine exteriorization
Number of subjects: 95
Study 32008386 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal uterine repair
Number of subjects: 95
Study 33802917 — intervention group
Group type: EXPERIMENTAL
Intervention: Food for Special Medical Purposes (FSMP) consisting of arginine, glutamine and HMB for 4 weeks
Number of subjects: 0
Study 32629738 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 120
Study 35667420 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with hyaluronic acid gel
Number of subjects: 343
Study 35881310 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized tele-exercise (SG)
Number of subjects: 30
Study 35881310 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 33753542 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-Calorie Refeeding (HCR) - 2000 kcals per day, increasing by 200 kcals per day
Number of subjects: 120
Study 33753542 — intervention group
Group type: COMPARATOR
Intervention: Lower-Calorie Refeeding (LCR) - 1400 kcals per day, increasing by 200 kcals every other day
Number of subjects: 120
Study 33753542 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-Calorie Refeeding (HCR)
Number of subjects: 120
Study 33753542 — intervention group
Group type: COMPARATOR
Intervention: Lower-Calorie Refeeding (LCR)
Number of subjects: 120
Study 33922802 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement
Number of subjects: 463
Study 33922802 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention alone
Number of subjects: 463
Study 35565117 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacitive and Resistive Electric Transfer (CRet) intervention
Number of subjects: 28
Study 35565117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 33507834 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care provision
Number of subjects: 2800
Study 33507834 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative service
Number of subjects: 2800
Study 33507834 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care group
Number of subjects: 2800
Study 36375455 — intervention group
Group type: EXPERIMENTAL
Intervention: Food vouchers
Number of subjects: 774
Study 36375455 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 774
Study 33709117 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR
Number of subjects: 74
Study 33709117 — intervention group
Group type: COMPARATOR
Intervention: CAU
Number of subjects: 74
Study 35972817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib (400 mg) combined with weekly carboplatin and paclitaxel chemotherapy followed by ribociclib maintenance
Number of subjects: 35
Study 33709375 — intervention group
Group type: EXPERIMENTAL
Intervention: NGS-based preimplantation genetic testing for aneuploidy (PGT-A) of trophectoderm biopsy
Number of subjects: 265
Study 32176342 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic simulator (Virteasy)
Number of subjects: 88
Study 32176342 — intervention group
Group type: COMPARATOR
Intervention: Conventional practical work on plastic analogue teeth (Kavo)
Number of subjects: 88
Study 36197167 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified low-flow oxygen therapy
Number of subjects: 213
Study 36197167 — intervention group
Group type: COMPARATOR
Intervention: Nonhumidified low-flow oxygen therapy
Number of subjects: 213
Study 33431381 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA testing
Number of subjects: 2808477
Study 33431381 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic PSA screening
Number of subjects: 2808477
Study 32846821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 0
Study 32846821 — intervention group
Group type: COMPARATOR
Intervention: Oral acetaminophen
Number of subjects: 0
Study 33855859 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled rumination time
Number of subjects: 60
Study 33855859 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness, shaping, and disengagement strategies
Number of subjects: 60
Study 33855859 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 60
Study 32502754 — intervention group
Group type: EXPERIMENTAL
Intervention: Woodcast®
Number of subjects: 0
Study 32502754 — intervention group
Group type: COMPARATOR
Intervention: Delta‐Cast®
Number of subjects: 0
Study 32502754 — intervention group
Group type: COMPARATOR
Intervention: OrthoTape
Number of subjects: 0
Study 34781363 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg daily
Number of subjects: 74
Study 34781363 — intervention group
Group type: COMPARATOR
Intervention: IVIG 1 or 2 g/kg
Number of subjects: 74
Study 34781363 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 74
Study 33104216 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP)
Number of subjects: 0
Study 32114905 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy Component Checklist (TCC)
Number of subjects: 230
Study 32114905 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating of adherence
Number of subjects: 230
Study 36401247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - complex intervention including individual, group, and community actions.
Number of subjects: 3062
Study 36401247 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - brief advice during usual doctor visits.
Number of subjects: 3062
Study 35435472 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib 400 mg BID
Number of subjects: 98
Study 35435472 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib 50-500 mg BID
Number of subjects: 98
Study 32282591 — intervention group
Group type: EXPERIMENTAL
Intervention: Exteriorization
Number of subjects: 180
Study 32282591 — intervention group
Group type: COMPARATOR
Intervention: In situ uterine repair
Number of subjects: 180
Study 35549686 — intervention group
Group type: COMPARATOR
Intervention: Serum vitamin D3 levels in control males
Number of subjects: 252
Study 35549686 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vitamin D3 levels in case and control groups
Number of subjects: 252
Study 34680131 — intervention group
Group type: EXPERIMENTAL
Intervention: Synolis VA
Number of subjects: 96
Study 32869578 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with rehabilitation training
Number of subjects: 60
Study 32869578 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation training
Number of subjects: 60
Study 34845555 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliary stent with double-strand 125I seeds radiotherapy drainage tube placement
Number of subjects: 42
Study 34845555 — intervention group
Group type: COMPARATOR
Intervention: Biliary stent with common drainage tube implantation
Number of subjects: 42
Study 34845555 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 32453667 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented aUCL repair with internal bracing
Number of subjects: 16
Study 32453667 — intervention group
Group type: COMPARATOR
Intervention: Modified docking technique (control)
Number of subjects: 16
Study 32453667 — intervention group
Group type: COMPARATOR
Intervention: Reconstruction techniques
Number of subjects: 16
Study 34273052 — intervention group
Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (eAT), N = 165
Number of subjects: 323
Study 34273052 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC), N = 158
Number of subjects: 323
Study 34682399 — intervention group
Group type: EXPERIMENTAL
Intervention: Local ischemic preconditioning (LIPC)
Number of subjects: 15
Study 34682399 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 15
Study 34682399 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study 34682399 — intervention group
Group type: COMPARATOR
Intervention: Sham (SHAM)
Number of subjects: 15
Study 34133971 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-life training intervention (4 small-group 4-hour educational sessions)
Number of subjects: 324
Study 34133971 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-life training intervention
Number of subjects: 324
Study 32601460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention targeting perceptions of social norms regarding pro-diversity attitudes
Number of subjects: 2490
Study 33859125 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis, cannabis-derived products, and synthetic cannabinoids
Number of subjects: 1
Study 34196106 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - 3 × 5 min administration of 200 mmHg sphygmomanometer on the arm (n=31)
Number of subjects: 60
Study 34196106 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (n=29)
Number of subjects: 60
Study 33152965 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 1–2 μg/kg
Number of subjects: 60
Study 33152965 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 6–7 μg/kg
Number of subjects: 60
Study 36052684 — intervention group
Group type: EXPERIMENTAL
Intervention: CCB+thiazide
Number of subjects: 405
Study 36052684 — intervention group
Group type: COMPARATOR
Intervention: ACE-inhibitor+thiazide
Number of subjects: 405
Study 36052684 — intervention group
Group type: EXPERIMENTAL
Intervention: CCB+ACE-inhibitor
Number of subjects: 405
Study 32997791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafast ultrasound following cervical magnetic stimulation (CMS)
Number of subjects: 13
Study 35482348 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary RT (60 Gy of RT with concurrent weekly cisplatin in node-positive patients)
Number of subjects: 61
Study 35482348 — intervention group
Group type: COMPARATOR
Intervention: TOS and neck dissection (ND) with adjuvant reduced-dose RT depending on pathologic findings
Number of subjects: 61
Study 35482348 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary RT
Number of subjects: 61
Study 35482348 — intervention group
Group type: COMPARATOR
Intervention: TOS and ND
Number of subjects: 61
Study 32252643 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification-based biopsychosocial approach to LBP management
Number of subjects: 0
Study 32252643 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsychosocially-oriented patient education booklet
Number of subjects: 0
Study 32252643 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based care strategies
Number of subjects: 0
Study 32673552 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 140
Study 32673552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 34488362 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (CT) - TESSYS technique under spinal endoscopy + drug therapy (coenzyme A, adenosine triphosphate, 10% glucose injection, 10% potassium chloride, vitamin B6, vitamin B12, dexamethasone, 20% mannitol, traditional Chinese medicine)
Number of subjects: 140
Study 34488362 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (CT)
Number of subjects: 140
Study 34488362 — intervention group
Group type: COMPARATOR
Intervention: Single operation group (SO)
Number of subjects: 140
Study 35943003 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 120
Study 35943003 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback combined with Vitamin D
Number of subjects: 120
Study 35943003 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 120
Study 35943003 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study 33561312 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab 6 mg/kg
Number of subjects: 88